Actively Recruiting
Performance Evaluation of ANI in Patients Under General Anesthesia With Remimazolam
Led by Catholic Kwandong University · Updated on 2024-05-30
30
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to determine whether Analgesia Nociception Index (ANI) can effectively reduce the dose of opioid in patients who underwent general anesthesia using remimazolam.
CONDITIONS
Official Title
Performance Evaluation of ANI in Patients Under General Anesthesia With Remimazolam
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 20 to 79 years undergoing general anesthesia with remimazolam
- Scheduled for robotic surgery
- Classified as American Society of Anesthesiologists physical class 1, 2, or 3
- Voluntarily agree in writing to participate in this clinical study
You will not qualify if you...
- Conditions affecting the autonomic nervous system
- Other conditions or diseases causing acute or chronic pain
- Numeric Rating Scale pain score of 1 or higher before anesthesia induction
- Taking medications that may affect the autonomic nervous system
- Any other reason investigator deems subject unsuitable for the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Catholic-Kwandong University, School of Medicine
Incheon, South Korea, 22711
Actively Recruiting
Research Team
J
Jungmin Lee
CONTACT
J
Joohyun Lee
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here